Vaxcyte, Inc.·4

Apr 6, 8:06 PM ET

Sauer Paul 4

4 · Vaxcyte, Inc. · Filed Apr 6, 2021

Insider Transaction Report

Form 4
Period: 2021-04-01
Sauer Paul
SVP Process Dev, Manufacturing
Transactions
  • Award

    Stock Option (right to buy)

    2021-04-01+40,00040,000 total
    Exercise: $20.93Exp: 2031-03-31Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION